Search alternatives:
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a largest » _ largest (Expand Search), a large (Expand Search), a latest (Expand Search)
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a largest » _ largest (Expand Search), a large (Expand Search), a latest (Expand Search)
-
28961
-
28962
-
28963
-
28964
Decreased plaque size in ORP8 KO BM recipients and increased plaque macrophage content after 9 weeks WTD feeding.
Published 2014“…After 9 weeks of WTD feeding following BMT, a decrease in plaque size could be measured. No difference was observed after 6 weeks of dietary challenge. …”
-
28965
-
28966
-
28967
-
28968
-
28969
-
28970
-
28971
-
28972
-
28973
-
28974
-
28975
-
28976
The Ras Antagonist, Farnesylthiosalicylic Acid (FTS), Decreases Fibrosis and Improves Muscle Strength in <em>dy</em> Mouse Model of Muscular Dystrophy
Published 2011“…FTS treatment significantly decreased RAS expression and activity. In addition, phosphorylation of ERK, a Ras downstream protein, was significantly decreased following FTS treatment in the <em>dy<sup>2J</sup></em>/<em>dy<sup>2J</sup></em> mice. …”
-
28977
-
28978
Increased mTOR and decreased AMPK activation in <i>Fnip1</i> null kidney tissue and renal tubular epithelial cells.
Published 2018“…<p>(A) Representative immunoblots showing decreased AMPK activation (pAMPKThr172) and increased mTORC1 activation (p-S6R, p-4EBP1) in total renal tissue from <i>Fnip1</i><sup><i>-/-</i></sup> and WT mice. …”
-
28979
-
28980
Human microRNA-299-3p decreases invasive behavior of cancer cells by downregulation of Oct4 expression and causes apoptosis
Published 2017“…</p><p>Methods and results</p><p>High throughput luciferase activity assay revealed the microRNA-299-3p to be the most effective in reducing gene expression of Oct4, which was confirmed by Western blot analysis and Oct4 promoter activity in a target luciferase assay. Furthermore, it could be demonstrated that downregulation of Oct4 by microRNAs-299-3p in breast cancer and fibrosarcoma cells lead to a decreased invasiveness in a microfluidic chip assay. …”